Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 381

1.

Reply to 19-00977.

Mossanen JC, Tacke F.

Gastroenterology. 2019 Aug 7. pii: S0016-5085(19)41193-1. doi: 10.1053/j.gastro.2019.07.057. [Epub ahead of print] No abstract available.

PMID:
31400369
2.

Correction to: Neutrophils are a main source of circulating suPAR predicting outcome in critical illness.

Gussen H, Hohlstein P, Bartneck M, Warzecha KT, Buendgens L, Luedde T, Trautwein C, Koch A, Tacke F.

J Intensive Care. 2019 Aug 2;7:40. doi: 10.1186/s40560-019-0397-x. eCollection 2019.

3.

Left- versus right-sided hepatectomy with hilar en-bloc resection in perihilar cholangiocarcinoma.

Bednarsch J, Czigany Z, Lurje I, Tacke F, Strnad P, Ulmer TF, Gaisa NT, Bruners P, Neumann UP, Lurje G.

HPB (Oxford). 2019 Aug 2. pii: S1365-182X(19)30617-3. doi: 10.1016/j.hpb.2019.07.003. [Epub ahead of print]

PMID:
31383591
4.

Evolving trends in machine liver perfusion: comments on clinical endpoints and selection criteria.

Czigany Z, Tacke F, Lurje G.

Gastroenterology. 2019 Jul 24. pii: S0016-5085(19)41124-4. doi: 10.1053/j.gastro.2019.02.051. [Epub ahead of print] No abstract available.

PMID:
31351055
5.

Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence.

Xu X, Guo X, Tacke F, Shao X, Qi X.

Ther Adv Chronic Dis. 2019 Jul 12;10:2040622319862693. doi: 10.1177/2040622319862693. eCollection 2019. Review.

6.

An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration.

Koppe C, Reisinger F, Wehr K, Vucur M, Trautwein C, Tacke F, Heikenwalder M, Luedde T.

Cancers (Basel). 2019 Jul 17;11(7). pii: E999. doi: 10.3390/cancers11070999.

7.

Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD.

Rinella ME, Tacke F, Sanyal AJ, Anstee QM; participants of the AASLD/EASL Workshop.

J Hepatol. 2019 Jul 9. pii: S0168-8278(19)30283-1. doi: 10.1016/j.jhep.2019.04.019. [Epub ahead of print] Review.

PMID:
31300231
8.

[Microbiome & NASH - partners in crime driving progression of fatty liver disease].

Wree A, Geisler LJ, Tacke F.

Z Gastroenterol. 2019 Jul;57(7):871-882. doi: 10.1055/a-0755-2595. Epub 2019 Jul 9. German.

PMID:
31288283
9.

Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD.

Rinella ME, Tacke F, Sanyal AJ, Anstee QM; participants of the AASLD/EASL Workshop.

Hepatology. 2019 Jul 9. doi: 10.1002/hep.30782. [Epub ahead of print]

PMID:
31287572
10.

[Nutrition Support Therapy in Critically Ill Patients].

Koch A, Bündgens L, Tacke F.

Dtsch Med Wochenschr. 2019 Jul;144(13):897-909. doi: 10.1055/a-0665-6749. Epub 2019 Jun 28. German.

PMID:
31252444
11.

Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs.

Tacke F, Boeker KHW, Klinker H, Heyne R, Buggisch P, Pathil A, Wiegand J, Cornberg M, Lange C, Berg T, Zeuzem S, Mauss S.

Liver Int. 2019 Jun 26. doi: 10.1111/liv.14186. [Epub ahead of print]

PMID:
31241820
12.

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.

Stueven AK, Kayser A, Wetz C, Amthauer H, Wree A, Tacke F, Wiedenmann B, Roderburg C, Jann H.

Int J Mol Sci. 2019 Jun 22;20(12). pii: E3049. doi: 10.3390/ijms20123049. Review.

13.

Decreased CTRP3 Plasma Concentrations Are Associated with Sepsis and Predict Mortality in Critically Ill Patients.

Yagmur E, Otto S, Koek GH, Weiskirchen R, Trautwein C, Koch A, Tacke F.

Diagnostics (Basel). 2019 Jun 21;9(2). pii: E63. doi: 10.3390/diagnostics9020063.

14.

The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent Clostridioides difficile infections in Germany.

Peri R, Aguilar RC, Tüffers K, Erhardt A, Link A, Ehlermann P, Angeli W, Frank T, Storr M, Glück T, Sturm A, Rosien U, Tacke F, Bachmann O, Solbach P, Stallmach A, Goeser F, Vehreschild MJ; German Clinical Microbiome Study Group (GCMSG).

United European Gastroenterol J. 2019 Jun;7(5):716-722. doi: 10.1177/2050640619839918. Epub 2019 Mar 21.

15.

Liver Macrophages: Old Dogmas and New Insights.

Guillot A, Tacke F.

Hepatol Commun. 2019 Apr 22;3(6):730-743. doi: 10.1002/hep4.1356. eCollection 2019 Jun. Review.

16.

Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer.

Kather JN, Pearson AT, Halama N, Jäger D, Krause J, Loosen SH, Marx A, Boor P, Tacke F, Neumann UP, Grabsch HI, Yoshikawa T, Brenner H, Chang-Claude J, Hoffmeister M, Trautwein C, Luedde T.

Nat Med. 2019 Jul;25(7):1054-1056. doi: 10.1038/s41591-019-0462-y. Epub 2019 Jun 3.

PMID:
31160815
17.

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis.

Krenkel O, Hundertmark J, Ritz TP, Weiskirchen R, Tacke F.

Cells. 2019 May 24;8(5). pii: E503. doi: 10.3390/cells8050503.

18.

Elevated CTRP1 Plasma Concentration Is Associated with Sepsis and Pre-Existing Type 2 Diabetes Mellitus in Critically Ill Patients.

Yagmur E, Buergerhausen D, Koek GH, Weiskirchen R, Trautwein C, Koch A, Tacke F.

J Clin Med. 2019 May 11;8(5). pii: E661. doi: 10.3390/jcm8050661.

19.

Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis.

Krenkel O, Hundertmark J, Abdallah AT, Kohlhepp M, Puengel T, Roth T, Branco DPP, Mossanen JC, Luedde T, Trautwein C, Costa IG, Tacke F.

Gut. 2019 May 10. pii: gutjnl-2019-318382. doi: 10.1136/gutjnl-2019-318382. [Epub ahead of print]

PMID:
31076404
20.

Neutrophils are a main source of circulating suPAR predicting outcome in critical illness.

Gussen H, Hohlstein P, Bartneck M, Warzecha KT, Buendgens L, Luedde T, Trautwein C, Koch A, Tacke F.

J Intensive Care. 2019 Apr 27;7:26. doi: 10.1186/s40560-019-0381-5. eCollection 2019. Erratum in: J Intensive Care. 2019 Aug 2;7:40.

21.

The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.

Lurje G, Bednarsch J, Czigany Z, Lurje I, Schlebusch IK, Boecker J, Meister FA, Tacke F, Roderburg C, Den Dulk M, Gaisa NT, Bruners P, Neumann UP.

Eur J Surg Oncol. 2019 Aug;45(8):1468-1478. doi: 10.1016/j.ejso.2019.04.019. Epub 2019 Apr 25.

PMID:
31053477
22.

Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis.

Rohwer N, Jumpertz S, Erdem M, Egners A, Warzecha KT, Fragoulis A, Kühl AA, Kramann R, Neuss S, Rudolph I, Endermann T, Zasada C, Apostolova I, Gerling M, Kempa S, Hughes R, Lewis CE, Brenner W, Malinowski MB, Stockmann M, Schomburg L, Faller W, Sansom OJ, Tacke F, Morkel M, Cramer T.

Oncogene. 2019 Jul;38(28):5670-5685. doi: 10.1038/s41388-019-0816-4. Epub 2019 May 1.

PMID:
31043706
23.

[Current and Future Therapy of Hepatitis B and D].

Tacke F.

Dtsch Med Wochenschr. 2019 Apr;144(8):528-534. doi: 10.1055/a-0807-7774. Epub 2019 Apr 15. Review. German.

PMID:
30986860
24.

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Malehmir M, Pfister D, Gallage S, Szydlowska M, Inverso D, Kotsiliti E, Leone V, Peiseler M, Surewaard BGJ, Rath D, Ali A, Wolf MJ, Drescher H, Healy ME, Dauch D, Kroy D, Krenkel O, Kohlhepp M, Engleitner T, Olkus A, Sijmonsma T, Volz J, Deppermann C, Stegner D, Helbling P, Nombela-Arrieta C, Rafiei A, Hinterleitner M, Rall M, Baku F, Borst O, Wilson CL, Leslie J, O'Connor T, Weston CJ, Adams DH, Sheriff L, Teijeiro A, Prinz M, Bogeska R, Anstee N, Bongers MN, Notohamiprodjo M, Geisler T, Withers DJ, Ware J, Mann DA, Augustin HG, Vegiopoulos A, Milsom MD, Rose AJ, Lalor PF, Llovet JM, Pinyol R, Tacke F, Rad R, Matter M, Djouder N, Kubes P, Knolle PA, Unger K, Zender L, Nieswandt B, Gawaz M, Weber A, Heikenwalder M.

Nat Med. 2019 Apr;25(4):641-655. doi: 10.1038/s41591-019-0379-5. Epub 2019 Apr 1.

PMID:
30936549
25.

Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo.

Ergen C, Niemietz PM, Heymann F, Baues M, Gremse F, Pola R, van Bloois L, Storm G, Kiessling F, Trautwein C, Luedde T, Lammers T, Tacke F.

Biomaterials. 2019 Jun;206:49-60. doi: 10.1016/j.biomaterials.2019.03.025. Epub 2019 Mar 22.

PMID:
30925288
26.

miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years.

Tacke F, Spehlmann ME, Vucur M, Benz F, Luedde M, Cardenas DV, Roy S, Loosen S, Hippe HJ, Frey N, Trautwein C, Koch A, Roderburg C, Luedde T.

Mediators Inflamm. 2019 Feb 24;2019:6714080. doi: 10.1155/2019/6714080. eCollection 2019.

27.

Risk of Stroke in Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Zheng K, Yoshida EM, Tacke F, Li Y, Guo X, Qi X.

J Clin Gastroenterol. 2019 Mar 13. doi: 10.1097/MCG.0000000000001201. [Epub ahead of print]

PMID:
30882537
28.

Prognostic Relevance of Altered Lymphocyte Subpopulations in Critical Illness and Sepsis.

Hohlstein P, Gussen H, Bartneck M, Warzecha KT, Roderburg C, Buendgens L, Trautwein C, Koch A, Tacke F.

J Clin Med. 2019 Mar 12;8(3). pii: E353. doi: 10.3390/jcm8030353.

29.

Mass migration to Europe: an opportunity for elimination of hepatitis B virus?

Thijssen M, Lemey P, Amini-Bavil-Olyaee S, Dellicour S, Alavian SM, Tacke F, Verslype C, Nevens F, Pourkarim MR.

Lancet Gastroenterol Hepatol. 2019 Apr;4(4):315-323. doi: 10.1016/S2468-1253(19)30014-7.

PMID:
30860067
30.

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma.

Loosen SH, Tacke F, Püthe N, Binneboesel M, Wiltberger G, Alizai PH, Kather JN, Paffenholz P, Ritz T, Koch A, Bergmann F, Trautwein C, Longerich T, Roderburg C, Neumann UP, Luedde T.

Carcinogenesis. 2019 Feb 26. pii: bgz033. doi: 10.1093/carcin/bgz033. [Epub ahead of print]

PMID:
30805627
31.

The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis.

Neumann K, Ostmann A, Breda PC, Ochel A, Tacke F, Paust HJ, Panzer U, Tiegs G.

Sci Rep. 2019 Feb 14;9(1):2038. doi: 10.1038/s41598-018-38432-3.

32.

Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C.

Mauss S, Buendgens L, Christensen S, Ingiliz P, Berger F, Hüppe D, Simon KG, Lutz T, Schewe K, Boesecke C, Tacke F.

Z Gastroenterol. 2019 Feb;57(2):139-147. doi: 10.1055/a-0752-0514. Epub 2019 Feb 12.

PMID:
30754058
33.

Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma.

Loosen SH, Hoening P, Puethe N, Luedde M, Spehlmann M, Ulmer TF, Cardenas DV, Roy S, Tacke F, Trautwein C, Neumann UP, Luedde T, Roderburg C.

Sci Rep. 2019 Feb 6;9(1):1489. doi: 10.1038/s41598-018-38352-2.

34.

CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell-Dependent Control of Senescence.

Mossanen JC, Kohlhepp M, Wehr A, Krenkel O, Liepelt A, Roeth AA, Möckel D, Heymann F, Lammers T, Gassler N, Hermann J, Jankowski J, Neumann UP, Luedde T, Trautwein C, Tacke F.

Gastroenterology. 2019 May;156(6):1877-1889.e4. doi: 10.1053/j.gastro.2019.01.247. Epub 2019 Jan 30.

PMID:
30710528
35.

The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers.

Bartneck M, Schrammen PL, Möckel D, Govaere O, Liepelt A, Krenkel O, Ergen C, McCain MV, Eulberg D, Luedde T, Trautwein C, Kiessling F, Reeves H, Lammers T, Tacke F.

Cell Mol Gastroenterol Hepatol. 2019;7(2):371-390. doi: 10.1016/j.jcmgh.2018.10.007. Epub 2018 Oct 18.

36.

Polypropylene mesh implantation for hernia repair causes myeloid cell-driven persistent inflammation.

Heymann F, von Trotha KT, Preisinger C, Lynen-Jansen P, Roeth AA, Geiger M, Geisler LJ, Frank AK, Conze J, Luedde T, Trautwein C, Binnebösel M, Neumann UP, Tacke F.

JCI Insight. 2019 Jan 24;4(2). pii: 123862. doi: 10.1172/jci.insight.123862. [Epub ahead of print]

37.

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.

Loosen SH, Lurje G, Wiltberger G, Vucur M, Koch A, Kather JN, Paffenholz P, Tacke F, Ulmer FT, Trautwein C, Luedde T, Neumann UP, Roderburg C.

PLoS One. 2019 Jan 17;14(1):e0210944. doi: 10.1371/journal.pone.0210944. eCollection 2019.

38.

Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease.

Weiskirchen R, Tacke F.

Cells. 2019 Jan 1;8(1). pii: E16. doi: 10.3390/cells8010016. Review.

39.

[Current Developments in Nutritional Therapy of Intensive Care Patients].

Koch A, Bündgens L, Herbers U, Trautwein C, Tacke F.

Dtsch Med Wochenschr. 2018 Dec;143(24):1759-1764. doi: 10.1055/a-0647-9417. Epub 2018 Dec 3. German.

PMID:
30508855
40.

CXCR6 protects from inflammation and fibrosis in NEMOLPC-KO mice.

Liepelt A, Wehr A, Kohlhepp M, Mossanen JC, Kreggenwinkel K, Denecke B, Costa IG, Luedde T, Trautwein C, Tacke F.

Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):391-402. doi: 10.1016/j.bbadis.2018.11.020. Epub 2018 Nov 24.

PMID:
30476545
41.

Response to the "Letter to the editor regarding article, 'High-mobility group box 1 as a biomarker in critically ill patients'."

Koch A, Tacke F.

J Clin Lab Anal. 2019 Mar;33(3):e22820. doi: 10.1002/jcla.22820. Epub 2018 Nov 25. No abstract available.

PMID:
30474271
42.

Clinical Practice Guidelines of the European Association for the study of the Liver - Advancing methodology but preserving practicability.

Cornberg M, Tacke F, Karlsen TH; European Association for the Study of the Liver.

J Hepatol. 2019 Jan;70(1):5-7. doi: 10.1016/j.jhep.2018.10.011. Epub 2018 Nov 9. No abstract available.

PMID:
30420159
43.

Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease.

Hundertmark J, Krenkel O, Tacke F.

Front Immunol. 2018 Oct 18;9:2418. doi: 10.3389/fimmu.2018.02418. eCollection 2018. Review.

44.

Circulating Levels of Osteopontin Predict Patients' Outcome after Resection of Colorectal Liver Metastases.

Loosen SH, Heise D, Dejong CH, Roy S, Tacke F, Trautwein C, Roderburg C, Luedde T, Neumann UP, Binnebösel M.

J Clin Med. 2018 Oct 26;7(11). pii: E390. doi: 10.3390/jcm7110390.

45.

Serum levels of kisspeptin are elevated in critically ill patients.

Luedde M, Spehlmann ME, Hippe HJ, Loosen SH, Roy S, Vargas Cardenas D, Vucur M, Frey N, Koch A, Luedde T, Trautwein C, Tacke F, Roderburg C.

PLoS One. 2018 Oct 17;13(10):e0206064. doi: 10.1371/journal.pone.0206064. eCollection 2018.

46.

An update on the recent advances in antifibrotic therapy.

Tacke F, Weiskirchen R.

Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1143-1152. doi: 10.1080/17474124.2018.1530110. Epub 2018 Oct 3. Review.

PMID:
30261763
47.

Effects of aging on liver microcirculatory function and sinusoidal phenotype.

Maeso-Díaz R, Ortega-Ribera M, Fernández-Iglesias A, Hide D, Muñoz L, Hessheimer AJ, Vila S, Francés R, Fondevila C, Albillos A, Peralta C, Bosch J, Tacke F, Cogger VC, Gracia-Sancho J.

Aging Cell. 2018 Dec;17(6):e12829. doi: 10.1111/acel.12829. Epub 2018 Sep 8.

48.

Visfatin Serum Levels Predict Mortality in Critically Ill Patients.

Koch A, Weiskirchen R, Krusch A, Bruensing J, Buendgens L, Herbers U, Yagmur E, Koek GH, Trautwein C, Tacke F.

Dis Markers. 2018 Aug 26;2018:7315356. doi: 10.1155/2018/7315356. eCollection 2018.

49.

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, Wai-Sun Wong V, Yilmaz Y, George J, Fan J, Vos MB.

Hepatology. 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251. Review.

PMID:
30179269
50.

microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.

Roy S, Hooiveld GJ, Seehawer M, Caruso S, Heinzmann F, Schneider AT, Frank AK, Cardenas DV, Sonntag R, Luedde M, Trautwein C, Stein I, Pikarsky E, Loosen S, Tacke F, Ringelhan M, Avsaroglu SK, Goga A, Buendia MA, Vucur M, Heikenwalder M, Zucman-Rossi J, Zender L, Roderburg C, Luedde T.

Gastroenterology. 2018 Dec;155(6):1951-1966.e26. doi: 10.1053/j.gastro.2018.08.032. Epub 2018 Aug 27.

PMID:
30165047

Supplemental Content

Support Center